Moderna
MRNA
#1444
Rank
ยฃ9.28 B
Marketcap
ยฃ24.02
Share price
-3.11%
Change (1 day)
-71.28%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ2.50 Billion

According to Moderna 's latest financial reports the company's total liabilities are ยฃ2.50 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ2.58 B-28.03%
2023-12-31ยฃ3.58 B-35.54%
2022-12-31ยฃ5.56 B-28.6%
2021-12-31ยฃ7.79 B122.51%
2020-12-31ยฃ3.50 B1008.18%
2019-12-31ยฃ0.31 B-7.08%
2018-12-31ยฃ0.34 B0.15%
2017-12-31ยฃ0.33 B-27.13%
2016-12-31ยฃ0.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ5.99 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ54.59 B 2,082.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ33.82 M-98.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.22 B 28.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.85 B 1,693.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ0.73 B-70.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ83.82 B 3,251.25%๐Ÿ‡บ๐Ÿ‡ธ USA